1. Altered type III collagen turnover measured in pre-treatment serum predicts outcome in metastatic melanoma patients treated with Ipilimumab. (March 2018) Authors: Jensen, C.; Madsen, D.; Hansen, M.; Schmidt, H.; Svane, I.; Karsdal, M.; Willumsen, N. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 1 Page Start: S7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗